CompletedNCT04488562

Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Erasmus Medical Center
Principal Investigator
M.S. Wijsenbeek, dr
Erasmus Medical Center
Enrollment
133 enrolled
Eligibility
18 years · All sexes
Timeline
2020 – 2022

Study locations (3)

Collaborators

Leiden University Medical Center · Amsterdam UMC, location VUmc · Dutch Society of Physicians for Pulmonology and Tuberculosis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04488562 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis →

← Back to all trials